Pinned Tweet
Welcome to AMEND USA! We're here to rasie awareness, educate, and connect individuals impacted by MEN disorders. We're glad you're here. Visit the link in our bio to view our website and resources!
#men1 #men2 #mendisorders
AMEND USA retweeted
👏Kudos to AMEND USA @AMENDInfoUSA for its new educational and advocacy activities.
📌ON FOCUS: John Metzcar, AMEND USA President, was featured by the Neuroendocrine Tumor Research Foundation - find out more: incalliance.org/amend-usa-ex…
#LetsTalkAboutNETs
AMEND USA retweeted
Join us this Thursday 27th August for this month's NETChatter meeting. DM for the link.
@PheoPara @carcinoid @CarcinoidNETs @CureNETs @NANETS1 @NETawarenesss @NCFCancer @netcancerday
We are so excited to join INCA, a global organization dedicated to increasing neuroendocrine cancer awareness and improving its care. We love this warm welcome and can’t wait to get started in the group and community!!
@netcancerday #LetsTalkAboutNETs
🔔INCA is thrilled to welcome @AMENDInfoUSA into the global NET patient community to work towards improving NET awareness and care.
👉INCA now represents 37 patient organizations in 29 countries on 6 continents.
✅Read more: incalliance.org/inca-welcome…
#LetsTalkAboutNETs
Come join us and @netcancerfound at Thursday's NET Chatter series!! It features the NCI's Dr. John Glod and his fantastic work with MEN2 and MTC! 1:00 pm ET, 10 AM PT
Patients, researchers, and clinicians all welcome!
@AmThyroidAssn @ThyCaInc @TheAAES @TheEndoSociety @TheAACE
Join us this Thursday 30th July at 6pm UK / 1pm EST for this month's NETChatter. DM for the link. @NCFCancer @PheoPara @AMENDInfoUSA @netcanceraware @carcinoid @netcanceraware @netcancerday @CureNETs #research #zebrastrong #LetsTalkAboutNets
AMEND USA retweeted
Join us this Thursday 30th July at 6pm UK / 1pm EST for this month's NETChatter. DM for the link. @NCFCancer @PheoPara @AMENDInfoUSA @netcanceraware @carcinoid @netcanceraware @netcancerday @CureNETs #research #zebrastrong #LetsTalkAboutNets
We've got big news! We are excited to work with @rezolutebio and raise awareness for their new study.
It’s Rare Disease Day! Watch this video for a quick introduction to MEN disorders. For more information, visit our website: amendusa.org/.
#RareDiseaseDay #ShowYourStripes #rarediseases #men1 #men2 #mendisorders
Happy Rare Disease Day from the AMEND USA team! We hope you join us in supporting and advocating for the MEN community.
#RareDiseaseDay #ShowYourStripes #rarediseases #men1 #men2 #mendisorders
MEN warrior and AMEND USA board member, Thomas Lehrich, shares his experience and passion for advocating for MEN disorders as rare diseases.
#RareDiseaseDay #ShowYourStripes #rarediseases #men1 #men2 #mendisorders
Happy Rare Disease Day! MEN disorders are genetic rare diseases. AMEND USA is dedicated to increasing awareness for these disorders. For more information, visit our website: amendusa.org/.
#RareDiseaseDay #ShowYourStripes #rarediseases #men1 #men2 #mendisorders
A Year-End Message of Gratitude from the AMEND USA Board of Directors - mailchi.mp/1205542ebbec/a-ye…
Today is World NET Cancer Day! Learn more in our newsletter: mailchi.mp/41bbdc6f1c89/toda…
Tomorrow is #WorldNETDay — coordinated by @INCAlliance to amplify the voice of the NET community and advance diagnostics, treatment, care, and research.
💜 Donate: amendusa.org/donate/
🧠 Take the INCA SCAN 2025 Survey: incalliance.org/scan2025/
#LetsTalkAboutNETs
AMEND USA retweeted
📣#pheo #para #PPGL #PHriends . . .
Share your experience by responding to the #SCAN2025 Global #NETs Survey. 🌎📝
#LetsTalkAboutNets
@HealingNET1 @RonnyAllan1 @NANETS1 @CureNETs @netcancerday @VHLAlliance @AMENDInfoUSA @APheipas @netcancerfound @n_nets @NECancerAus
#NETCancerDay is on November 10th.
✅Share your experience as NET patient, caregiver or healthcare professional through #SCAN2025 Global Survey to advocate for early NET diagnosis and equal access to care: incalliance.org/scan2025/ #LetsTalkAboutNETs #WeSCAN
3 Ways to Take Charge of MEN: July Newsletter - Stories That Empower: Genetic Insights, Expert Guidance, and Real-Life Experiences - mailchi.mp/efa4d971790b/3-wa…
AMEND USA retweeted
Dr James Yao @MDAndersonNews observes that, prior to 2011, the only FDA-approved systemic therapy for pancreatic neuroendocrine tumors was streptozocin! What a remarkable decade-plus of progress in the field 🤯 and yet, for our patients, we have miles to go before we sleep …






























